And u can buy a decent Chinese made CPAP for a fraction of Resmed's. And the drop in share price for both RMD and FPH would suggested the assumption of success in treating cardiac failure was heavily built into the share prices before. Despite this I do remain optimistic in the short to medium term as the funds would generally buy back in as they believe there many blue chip biotech in this country.
- Forums
- ASX - By Stock
- RMD
- Where does this end?
Where does this end?, page-43
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$28.60 |
Change
-0.500(1.72%) |
Mkt cap ! $18.16B |
Open | High | Low | Value | Volume |
$28.50 | $28.87 | $28.33 | $85.93M | 2.994M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1039 | $28.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$28.60 | 42301 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1039 | 28.530 |
1 | 12000 | 28.520 |
1 | 300 | 28.510 |
5 | 2825 | 28.500 |
2 | 560 | 28.450 |
Price($) | Vol. | No. |
---|---|---|
28.600 | 36654 | 3 |
28.640 | 11121 | 2 |
28.650 | 6932 | 1 |
28.660 | 7270 | 1 |
28.680 | 1000 | 1 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online